Whole kombucha,
does it really help with Lower fasting glucose in type 2 diabetes?
research showsThe grade is D with 24 points. Fifteen adults started and 12 entered analysis in a four-week crossover trial, but only seven completed the primary fasting-glucose analysis in both periods. Glucose fell within the kombucha period from 164.3 to 116.1 mg/dL, while the week-four comparison with control drink was null at p=0.265.
ads claimMeasured microbes and organic acids, or a within-period glucose fall, do not establish lower fasting glucose than a control drink.
Useful facts when choosing a product
- The study kombucha contained 1.1×10⁶ CFU/mL lactic-acid bacteria, 9.5×10⁵ CFU/mL acetic-acid bacteria, 7.5×10⁵ CFU/mL yeast, organic acids, and about 1.5% ethanol.
- Sodium per 240 mL serving was not reported, so its percentage of the Daily Value cannot be calculated. Residual sugar was present, but the exact serving amount could not be confirmed in the publicly accessible material.
- Histamine, tyramine, nitrite, and N-nitroso compounds in the test product were not confirmed.
- A specific origin and date were not confirmed; no identified East Asian classical drink can be equated with modern commercial kombucha.
- Verdict 1509 is D with 37 points for kefir in the same indication. Kefir and kombucha are different whole fermented foods.
- Verdict 099 is C with 52 points for a strain isolated from kimchi, verdict 055 is D with 34 points for isolated nattokinase, and verdict 407 is C with 48 points for isolated poly-gamma-glutamic acid. These are not the same intervention as whole kombucha with its substrate, mixed microbes, alcohol, sugar, and possible amines.
What the research actually shows
The 2023 Frontiers in Nutrition paper by Mendelson C et al. was checked against the prospectively filed NCT04107207 record. The double-blind crossover design used 240 mL daily for four weeks and matched its registered endpoint, but only seven participants contributed to the primary analysis and the comparison with control was null. Craft Kombucha donated beverages but reportedly had no data access or analytic role; several authors disclosed interests related to Synbiotic Health.
Why this is classified as D (24)
The registered primary comparison with control was null, and no between-treatment confidence interval excludes meaningful benefit. This single tiny, short crossover trial analyzed completers, giving D with 24 points.
Counterpoint. The within-period decrease supports a larger trial, but efficacy requires success against the control drink.
Rejudgment record. Cross-check applied — Paper-to-registry comparison confirming seven primary-analysis completers, week-four p=0.265, funding, and disclosed interests
| Endpoint | S | Surrogate marker - laboratory or imaging measures |
| Replication | R1 | Single confirmatory trial |
| Independence | I1 | Mixed funding sources |
| Effect size | E0 | Null |
| Precision | CX | No pooled confidence interval could be confirmed |
The scoring table and the verdict agree (D).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| The study kombucha contains microbes, organic acids, and ethanol | ? | This is a measured composition fact, not a graded clinical outcome. |
| Whole kombucha lowers fasting glucose more than a control drink | D | The prospectively registered primary between-drink comparison was null. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Double-blind randomized crossover trial, four weeks per period | 7 | Craft Kombucha donated drinks with no reported analytic role; some authors disclosed Synbiotic Health interests | Mean self-measured fasting glucose | Kombucha period 164.3±66.4 to 116.1±43.2 mg/dL; week-four comparison with control p=0.265 | Direct null between-treatment result for the prospectively registered primary endpoint |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-08-02).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-02 · Corrections: none
Cite this verdict
[Chamgap] Whole kombucha x fasting glucose in type 2 diabetes — Evidence Grade D·24. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/whole-kombucha-type-2-diabetes-fasting-glucose/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.